Olivier Bouchaud Selected Research

Olivier Bouchaud Research Topics

Disease

10	Malaria 11/2021 - 06/2007
9	Falciparum Malaria (Plasmodium falciparum Malaria) 05/2021 - 04/2005
6	COVID-19 06/2022 - 01/2020
5	HIV Infections (HIV Infection) 01/2020 - 06/2013
3	Inflammation (Inflammations) 11/2021 - 01/2012
3	Cardiovascular Diseases (Cardiovascular Disease) 11/2021 - 11/2008
3	Cardiotoxicity 05/2021 - 07/2002
3	Infections 01/2020 - 01/2017
3	Insulin Resistance 04/2015 - 01/2012
2	Overweight 11/2021 - 04/2015
2	Obesity 11/2021 - 10/2021
2	Fever (Fevers) 02/2019 - 06/2012
2	Fibrosis (Cirrhosis) 01/2017 - 01/2016
2	Tuberculosis (Tuberculoses) 03/2016 - 08/2011
2	Vomiting 06/2012 - 05/2012
2	Heart Diseases (Heart Disease) 12/2009 - 07/2002
1	Bacteriuria 01/2022
1	Rheumatic Diseases (Rheumatism) 01/2022
1	Anemia 11/2021
1	Cardiac Arrhythmias (Arrythmia) 11/2021
1	Weight Gain 11/2021
1	Hemolysis 11/2021
1	Hypertriglyceridemia 10/2021
1	Hypertension (High Blood Pressure) 10/2021
1	Fatty Liver 01/2021
1	Malnutrition (Nutritional Deficiencies) 11/2020
1	Pneumonia (Pneumonitis) 10/2020
1	Septic Shock (Toxic Shock Syndrome) 12/2019
1	Bites and Stings (Sting) 02/2019
1	Acquired Immunodeficiency Syndrome (AIDS) 01/2019
1	Loiasis 11/2018
1	Schistosomiasis (Bilharziasis) 01/2017
1	Chronic Disease (Chronic Diseases) 12/2016
1	Parasitemia 10/2016
1	Pneumococcal Infections 10/2016
1	Angioedema 02/2016
1	Poliomyelitis (Polio) 09/2015
1	Tetanus 09/2015
1	Hepatitis B 09/2015
1	Yellow Fever 09/2015
1	Diphtheria 09/2015
1	Diarrhea 08/2015
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 04/2015
1	Lipodystrophy 04/2015
1	Autoimmune Diseases (Autoimmune Disease) 08/2014

Drug/Important Bio-Agent (IBA)

8	Pharmaceutical PreparationsIBA 05/2021 - 04/2005
5	proguanil drug combination atovaquone (malarone)FDA Link 10/2016 - 04/2005
4	VaccinesIBA 01/2022 - 05/2012
3	C-Reactive ProteinIBA 11/2021 - 01/2012
3	Oxygen (Dioxygen)IBA 10/2021 - 10/2020
3	piperaquineIBA 05/2021 - 12/2019
3	artenimol (dihydroartemisinin)IBA 05/2021 - 12/2019
2	Insulin (Novolin)FDA Link 11/2021 - 01/2012
2	ArtesunateIBA 11/2021 - 12/2019
2	Biomarkers (Surrogate Marker)IBA 01/2021 - 10/2016
2	AlbuminsIBA 11/2020 - 10/2016
2	RNA (Ribonucleic Acid)IBA 01/2017 - 06/2013
2	AntigensIBA 01/2017 - 06/2011
2	ProcalcitoninIBA 10/2016 - 03/2006
2	Quinine (Quinson)FDA Link 10/2016 - 04/2005
2	Chloroquine (Aralen)FDA LinkGeneric 01/2013 - 04/2005
2	Mefloquine (Lariam)FDA LinkGeneric 06/2012 - 12/2009
2	Antimalarials (Antimalarial Agents)IBA 05/2012 - 09/2007
2	halofantrine (Halfan)FDA Link 12/2009 - 07/2002
1	mRNA VaccinesIBA 06/2022
1	LipidsIBA 11/2021
1	AdiponectinIBA 11/2021
1	Type II Tumor Necrosis Factor ReceptorsIBA 11/2021
1	LeptinIBA 11/2021
1	Lipopolysaccharide ReceptorsIBA 11/2021
1	Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA 11/2021
1	Interleukin-6 (Interleukin 6)IBA 11/2021
1	EnzymesIBA 11/2021
1	Glucose (Dextrose)FDA LinkGeneric 11/2021
1	HDL CholesterolIBA 10/2021
1	Prealbumin (Transthyretin)IBA 11/2020
1	Blood Proteins (Serum Proteins)IBA 11/2020
1	ZincIBA 11/2020
1	DNA (Deoxyribonucleic Acid)IBA 01/2020
1	Norepinephrine (Noradrenaline)FDA LinkGeneric 12/2019
1	SolutionsIBA 12/2019
1	artemisinin (artemisinine)IBA 12/2019
1	Ribavirin (Virazole)FDA LinkGeneric 01/2017
1	Praziquantel (Biltricide)FDA Link 01/2017
1	Serum AlbuminIBA 10/2016
1	GoldIBA 03/2016
1	Antiviral Agents (Antivirals)IBA 01/2016
1	AntibodiesIBA 09/2015
1	LactamsIBA 08/2015
1	Protease Inhibitors (Protease Inhibitor)IBA 04/2015
1	Immunosuppressive Agents (Immunosuppressants)IBA 08/2014

Therapy/Procedure

12	Therapeutics 11/2021 - 11/2008
4	Chemoprevention 02/2019 - 06/2007
3	Highly Active Antiretroviral Therapy (HAART) 11/2021 - 06/2013
3	Art Therapy 01/2020 - 09/2015
1	Biological Therapy 01/2022
1	Nutritional Support (Artificial Feeding) 11/2020
1	Activities of Daily Living (ADL) 01/2020
1	Resuscitation 12/2019
1	Mosquito Nets 02/2019